Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating nephritis

A composition and drug technology, applied in the field of pharmaceutical compositions for the treatment of nephritis, can solve the problems of patients' mental and economic overload, thrombocytopenia, easy recurrence, etc. Effect

Inactive Publication Date: 2006-12-27
陈汝德
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, there are still many problems in these common methods for treating nephritis at present, such as: symptomatic treatment and control of complications cannot cure the disease from the root cause, and it is difficult to treat thoroughly, so the disease is prone to repeated attacks
Antibiotic treatment also often produces drug resistance. After long-term use, the curative effect is significantly reduced, and the disease is prone to relapse. At the same time, some serious adverse reactions may occur, such as anemia, thrombocytopenia, and leukopenia. disorders, leading to new diseases, etc.
However, if hormone therapy is used, it is generally not suitable for long-term use due to the strong masking effect of hormones on the disease, obvious side effects, and easy recurrence.
In addition, patients with nephritis often need long-term medication, and these symptomatic drugs, antibiotics, hormones, etc. are all inexpensive, which often makes patients overwhelmed both mentally and financially.
[0010] At present, the research of traditional Chinese medicine in the treatment of nephritis has made great progress. The use of suitable Chinese medicines for the treatment of nephritis, on the one hand, has obvious curative effect and is not easy to relapse. On the other hand, it has no pain, no toxic side effects, and low cost. Favored by doctors and many patients with nephritis; but currently there are only a few varieties of Chinese patent medicines that can be used to treat nephritis, such as Buzhong Yiqi Wan, and some other varieties are still in the research stage, which is far from meeting the needs of clinical treatment of nephritis patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The pharmaceutical composition of the present embodiment is made from the bulk drug of the following weight proportions:

[0030] 8 parts of ephedra, 14 parts of gypsum, 14 parts of cork, 15 parts of silver flower

[0031] Forsythia 20 parts, Akebia 10 parts, Yiren 40 parts, Alisma 12 parts

[0032] 10 parts of polyporus, 10 parts of big belly skin, 40 parts of Houttuynia cordata.

Embodiment 2

[0034] The pharmaceutical composition of the present embodiment is made from the bulk drug of the following weight proportions:

[0035] 5 parts of ephedra, 10 parts of gypsum, 20 parts of cork, 30 parts of silver flower

[0036] Forsythia 15 parts, Akebia 20 parts, Coix seed 35 parts, Alisma 5 parts

[0037] 15 parts of Polyporus, 5 parts of Dabupi, 35 parts of Houttuynia cordata.

Embodiment 3

[0039] The pharmaceutical composition of the present embodiment is made from the bulk drug of the following weight proportions:

[0040] 15 parts of ephedra, 20 parts of gypsum, 5 parts of cork, 10 parts of silver flower

[0041] Forsythia 25 parts, Akebia 1 part, Coix seed 45 parts, Alisma 20 parts

[0042] 1 part Polyporus, 1 part Dabupi, 45 parts Houttuynia cordata.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating nephritis wherein the raw material herbs include (by weight ratio) Chinese ephedra 1-15 parts, calcium sulphate 5-30 parts, yellow corktree bark 5-30 part, honeysuckle flower 5-30 parts, capsule of weeping forsythia 10-30 parts, aristolochia stem 1-20 parts, seed of Job's tears 30-50 parts, alisol 1-20 parts, polyporus umbellatus 1-20 parts, areca catecha 1-20 parts and cordate houttuynia 30-50 parts.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating nephritis. Background technique [0002] Nephritis is a non-suppurative inflammatory lesion of both kidneys. Kidney edema, high blood pressure, proteinuria and other phenomena due to damage to the renal corpuscles are the most common types of kidney disease. Once suffering from nephritis, if it is not properly controlled, with the development of the disease, renal function decline and renal dysfunction will gradually appear, ranging from loss of labor force, affecting the normal work and study life of the patient; severe loss of life, seriously endangering human health . [0003] There are many types of nephritis, such as acute (glomerular) nephritis, chronic (glomerular) nephritis, pyelonephritis, occult nephritis, allergic purpura nephritis (purpuric nephritis), lupus erythematosus nephritis (lupus nephritis) and so on. The most common are acute glomerulonephritis, chronic glomerul...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/899A61K36/9068A61P13/12A61K33/06
Inventor 陈汝德
Owner 陈汝德
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products